Security key
76152G100
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (RVPH)
CUSIP: 76152G100
Q1 2023 13F Holders as of 31 Mar 2023
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 13,730,837
- Total 13F shares
- 1,375,662
- Share change
- +72,130
- Total reported value
- $5,761,612
- Put/Call ratio
- 92%
- Price per share
- $4.19
- Number of holders
- 22
- Value change
- +$298,180
- Number of buys
- 8
- Number of sells
- 14
Report period
Q1 2023
Institutions
22
Top holders
10
RVPH full security history
Newer quarter: Q2 2023
Previous quarter: Q4 2022
REVIVA PHARMACEUTICALS HOLDINGS, INC. SEC filings
REVIVA PHARMACEUTICALS HOLDINGS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 76152G100
Recent filing periods:
Top shareholders of RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
3.4%
|
466,417
|
$1,982,272 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
145,430
|
$618,000 | — | 31 Dec 2022 | |
| EMC Capital Management |
13F
|
Company |
0.9%
|
123,915
|
$527,000 | — | 31 Dec 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.67%
|
91,530
|
$389,003 | — | 31 Dec 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.62%
|
84,954
|
$361,055 | — | 31 Dec 2022 | |
| XTX Topco Ltd |
13F
|
Company |
0.43%
|
58,475
|
$248,519 | — | 31 Dec 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.34%
|
47,035
|
$199,899 | — | 31 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.32%
|
44,400
|
$188,700 | — | 31 Dec 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.28%
|
38,600
|
$164,050 | — | 31 Dec 2022 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.25%
|
34,500
|
$146,625 | — | 31 Dec 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.23%
|
31,253
|
$132,825 | — | 31 Dec 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.21%
|
29,222
|
$124,194 | — | 31 Dec 2022 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.18%
|
24,125
|
$102,531 | — | 31 Dec 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.15%
|
20,300
|
$86,000 | — | 31 Dec 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.11%
|
14,536
|
$61,778 | — | 31 Dec 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.09%
|
12,232
|
$51,986 | — | 31 Dec 2022 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.08%
|
10,303
|
$43,000 | — | 31 Dec 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.07%
|
10,037
|
$43,000 | — | 31 Dec 2022 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.07%
|
9,299
|
$39,521 | — | 31 Dec 2022 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
0.05%
|
6,814
|
$28,959 | — | 31 Dec 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
109
|
$463 | — | 31 Dec 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
34
|
$144 | — | 31 Dec 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
12
|
$51 | — | 31 Dec 2022 | |
| VEDANTA PARTNERS, LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
1,127,207
mixed-class rows
|
— | — | 08 Sep 2022 |
Institutional Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (RVPH) as of Q1 2023
As of 31 Mar 2023,
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (RVPH) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,375,662 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, EMC Capital Management, COLONY GROUP LLC, BlackRock Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, TANG CAPITAL MANAGEMENT LLC, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, and SABBY MANAGEMENT, LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
23
Q1 2023 holders
22
Holder diff
-1
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.